Jonathan Duskin - Jun 16, 2021 Form 4 Insider Report for Citi Trends Inc (CTRN)

Role: Director
Signature: /s/ Jonathan Duskin
Stock symbol: CTRN
Transactions as of: Jun 16, 2021
Transactions value $: $0
Form type: 4
Date filed: 6/17/2021, 06:09 PM
Next filing: Jan 10, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CTRN	Common Stock, $0.01 par value	Award	$0	+936	+12.72%	$0.00	8.29K	Jun 16, 2021	Direct	F1
holding	CTRN	Common Stock, $0.01 par value						237K	Jun 16, 2021	By Macellum SPV III, LP	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of restricted stock awarded to Mr. Duskin in his capacity as a director of the Issuer. The restricted stock will vest on the earlier of (i) one year after the date of grant, which would be June 16, 2022 or (ii) the date of the annual meeting of the Company's stockholders in 2022, provided Mr. Duskin is a director of the Issuer at such time.
F2	Represents securities of the Issuer owned directly by Macellum SPV III, LP ("Macellum SPV"). Macellum Management, LP ("Macellum Management") serves as the investment manager of Macellum SPV. Macellum Advisors GP, LLC ("Macellum GP") serves as the general partner of Macellum Management and Macellum SPV. As the sole member of Macellum GP, Mr. Duskin may be deemed to beneficially own the securities of the Issuer owned directly by Macellum SPV. Mr. Duskin disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Content

Represents shares of restricted stock awarded to Mr. Duskin in his capacity as a director of the Issuer. The restricted stock will vest on the earlier of (i) one year after the date of grant, which would be June 16, 2022 or (ii) the date of the annual meeting of the Company's stockholders in 2022, provided Mr. Duskin is a director of the Issuer at such time.

Represents securities of the Issuer owned directly by Macellum SPV III, LP ("Macellum SPV"). Macellum Management, LP ("Macellum Management") serves as the investment manager of Macellum SPV. Macellum Advisors GP, LLC ("Macellum GP") serves as the general partner of Macellum Management and Macellum SPV. As the sole member of Macellum GP, Mr. Duskin may be deemed to beneficially own the securities of the Issuer owned directly by Macellum SPV. Mr. Duskin disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.